在不适合荷尔蒙治疗的妇女中,因更年期而导致的血管运动症状的费索利尼坦效应
Nanette Santoro1, Genevieve Neal-Perry2, Petra Stute3
1Department of Obstetrics and Gynecology, School of Medicine, University of Colorado, Aurora, CO, USA.
Current medical research and opinion
|March 5, 2025
概括
费索利尼坦有效降低了适度至严重的血管运动症状 (VMS),并改善了不适合激素治疗 (HT) 的女性的睡眠. 治疗耐受性很好,在这个人群中证明了其安全性和有效性.
科学领域:
- 更年期研究研究更年期研究.
- 药理学 药理学是指药理学的学科.
- 临床试验中的临床试验.
背景情况:
- 血管运动症状 (VMS),包括热和夜间出汗,显著影响更年期妇女的生活质量.
- 激素治疗 (HT) 是一种常见的VMS治疗方法,但由于禁忌或医疗问题,它不适合某些患者群体.
- 在无法使用HT的妇女中,需要有效和安全的非激素治疗选择来治疗VMS.
研究的目的:
- 为了评估fezolinetant在治疗中度至重度VMS的疗效和安全性,在不适合激素治疗 (HT) 的妇女中.
- 分析来自SKYLIGHT 1和SKYLIGHT 2临床试验的综合数据,以提供关于fezolinetant有效性的强有力的证据.
- 评估fezolinetant对与VMS相关的睡眠障碍的影响.
主要方法:
- 两项双盲,安慰剂对照研究 (SKYLIGHT 1和2) 的综合分析,涉及40-65岁的女性,患有中度至严重的VMS.
- 参与者每天接受安慰剂,费佐利内坦30毫克或费佐利内坦45毫克,持续12周,随后进行延长期.
- 研究人口包括不适合HT的女性,根据医疗原因分为子组.
主要成果:
- 费索利内坦,特别是45毫克的剂量,在12周后与安慰剂相比,显著降低了VMS的频率和严重程度 (p < .001).
- 早在第4周就观察到VMS的改善.
- 与安慰剂相比,费佐利内坦治疗导致睡眠障碍得分显著改善 (PROMIS-SD SF 8b) (p = .005).
- 治疗出现的不良事件的发生率在费佐利内坦45毫克组 (39.4%) 和安慰剂组 (41.3%) 之间是可比的,表明耐受性良好.
结论:
- 费索利内坦是有效的非激素治疗方法,用于减少绝经期妇女不适合HT的VMS频率和严重程度.
- 该药物表现出良好的安全性,并改善了这一群体的睡眠障碍.
- 这些发现支持fezolinetant作为一种可行的治疗选择,用于管理在女性与荷尔蒙治疗的禁忌的VMS.
相关概念视频
Menopause
113
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
113
Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
Antidepressant Drugs: MAOIs and Other Agents
175
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
175
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
171
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
171
Antiepileptic Drugs: Potassium Channel Activators
140
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
140
Anxiolytic Drugs: Benzodiazepines and Buspirone
443
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
443


